Generate Partners with Novartis to Advance Protein Therapeutics
Slice of Healthcare Team
Sep 26, 2024
Key Highlights
- Generateand Novartis announce multi-target collaboration to develop protein therapeutics.
- Generative AI to enhance drug discovery using "The Generate Platform."
- Generate to receive $65 million upfront and over $1 billion in potential milestone payments.
- Collaboration accelerates next-gen biologics development in various disease areas.
Source: Business Wire
Notable Quotes
“ This collaboration offers an opportunity to leverage the unique strengths of our respective companies...to bring forward new medicines with transformative potential for patients. ”
Fiona Marshall, President of Biomedical Research at Novartis
“ Partnering with Novartis allows us to broaden the use of our cutting-edge generative biology platform to tackle even more areas of unmet medical need. ”
Mike Nally, CEO at Generate
-2e14ed90-63f5-4ce1-84fc-3fa9506b84be.png&w=3840&q=75)
